Emerging Therapeutic Strategies for Targeting Chronic Myeloid Leukemia Stem Cells

Figure 2

Monitoring response to therapy in CML. Three levels of disease control can be defined in CML: Complete Hematologic Response (CHR), Cytogenetic Response (CyR) (Minor, Partial or Complete) and Molecular Response (MR) (Major or Complete) (Adapted from [33]).